Dr. Iberri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
# Stanford
Stanford, CA 94305Phone+1 650-498-4560
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 2013 - 2016- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2013
- Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 2010 - 2011
University of Vermont College of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2011 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 2 citationsBalancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck.David J Iberri, A Dimitrios Colevas
The Oncologist. 2016-03-01 - 218 citationsPostibrutinib outcomes in patients with mantle cell lymphoma.Peter Martin, Kami J. Maddocks, John P. Leonard, Jia Ruan, Andre Goy
Blood. 2016-03-24 - 4 citationsTelescope punch biopsy of normal-appearing skin to diagnose intravascular lymphoma.Mårten C.G. Winge, David J. Iberri, Roberto A. Novoa, Bernice Y. Kwong, Lisa C. Zaba
The British Journal of Dermatology. 2021-02-01
Press Mentions
Evaluating Selinexor in Patients with Relapsed/Refractory DLBCLSeptember 1st, 2020
Has the FDA Been Approving Some Drugs Without Proper Evidence?August 20th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
